Quantcast
Home / DC News / FDA’s fast-tracking of drugs called ‘risky’

FDA’s fast-tracking of drugs called ‘risky’

The Food and Drug Administration’s expedited approval of drugs like the blood thinner Pradaxa may be endangering U.S. consumers, according to a new column in the Journal of the American Medical Association.